Literature DB >> 8431167

Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C.

P T Khaw1, J W Doyle, M B Sherwood, I Grierson, G Schultz, S McGorray.   

Abstract

Rabbits undergoing full-thickness glaucoma filtering surgery were exposed for 5 minutes to one of three intraoperative treatments: (1) distilled water; (2) fluorouracil, 50 mg/mL; or (3) mitomycin C, 0.4 mg/mL. Tissue samples were taken from the subconjunctival and scleral tissues at the treated area and 90 degrees and 180 degrees from the center of the treated area and the adjacent cornea 2 mm from the limbus, 1 hour, 5 days, and 30 days postoperatively. The biopsy specimens were then placed in tissue culture media and the fibroblast outgrowths measured. Five-minute intraoperative treatments with fluorouracil resulted in a reversible delay of fibroblast outgrowths from treated subconjunctival and scleral tissues of just over 1 week in this model, whereas treatment with mitomycin C, 0.4 mg/mL, resulted in prolonged inhibition of at least 30 days. These effects were localized to the area treated. The many clinical implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431167     DOI: 10.1001/archopht.1993.01090020117035

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  40 in total

Review 1.  A review of in vivo animal studies in retinal prosthesis research.

Authors:  Dimiter R Bertschinger; Evgueny Beknazar; Manuel Simonutti; Avinoam B Safran; José A Sahel; Serge G Rosolen; Serge Picaud; Joel Salzmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

Review 2.  Aging and the cornea.

Authors:  R G Faragher; B Mulholland; S J Tuft; S Sandeman; P T Khaw
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

3.  Connexin43 modulation inhibits scarring in a rabbit eye glaucoma trabeculectomy model.

Authors:  Narmadai C Deva; Jie Zhang; Colin R Green; Helen V Danesh-Meyer
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Sponge delivery variables and tissue levels of 5-fluorouracil.

Authors:  M R Wilkins; N L Occleston; A Kotecha; L Waters; P T Khaw
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 5.  Trabeculectomy with intraoperative sponge 5-fluorouracil in Afro-Caribbeans.

Authors:  Y Lachkar; M Leyland; P Bloom; C Migdal
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

6.  Dose, timing and frequency of subconjunctival 5-fluorouracil injections after glaucoma filtering surgery.

Authors:  Eva Kristina Reinthal; Paul Oliver Denk; Matthias Grüb; Dorothea Besch; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-17       Impact factor: 3.117

7.  Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines.

Authors:  Justus G Garweg; Maria Wegmann-Burns; David Goldblum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-10       Impact factor: 3.117

8.  The effects of repetitious topical use of mitomycin C on antrostomy patency in maxillary antrostomy created rabbit model.

Authors:  Ali Kavuzlu; Necmi Arslan; Eren Tastan; Ahmet Islam; Huseyin Ustun; Filiz Aydogan
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-05       Impact factor: 2.503

9.  Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.

Authors:  C H Kon; N L Occleston; A Foss; C Sheridan; G W Aylward; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

10.  Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor.

Authors:  Jennifer Sapitro; Jeffrey J Dunmire; Sarah E Scott; Vijay Sutariya; Werner J Geldenhuys; Michael Hewit; Beatrice Y J T Yue; Hiroshi Nakamura
Journal:  Mol Vis       Date:  2010-09-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.